Investigational Site Number 826-009

London SW170QT

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed